Tka clinical trials

Explore recruiting tka clinical trials.

Recruiting tka studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tka trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multicenter, Randomized, Open-Label, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX).

Bulgaria, Lithuania, Poland, Hungary, Latvia, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Feasibility of short-term temporary discontinuation of serotonin reuptake inhibitors in patients planned for hip or knee arthroplasty

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

Greece, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sterile allogeneic spongioflex® allografts as partial meniscal replacement after incomplete meniscal loss, an investigator-initiated trial

Germany

Therapeutic use (Phase IV) EU CTIS Study details

A Multicenter, Randomized, Open-Label, Blinded Endpoint Evaluation, Active-Controlled Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing Elective Primary Unilateral Total Knee Arthroplasty.

Latvia, Bulgaria, Hungary, Czechia, Poland, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Open-Label, Active-Control Study of REGN9933, a Factor XI Monoclonal Antibody, for Prevention of Venous Thromboembolism after Elective, Unilateral, Total Knee Arthroplasty

Lithuania, Latvia, Poland, Hungary, Bulgaria, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Tka trials by city

Tka in Toronto Tka in Vancouver Tka in Montreal Tka in Calgary Tka in Edmonton Tka in Ottawa Tka in Winnipeg Tka in Quebec City Tka in Hamilton Tka in Kitchener Tka in London Tka in Halifax Tka in New York Tka in Los Angeles Tka in Chicago Tka in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease